This official launch marks the publication of the report of the EASL–Lancet Liver Commission: Protecting the next generation of Europeans against liver disease complications and premature mortality. This prestigious event is a culmination of many years of collaboration together, with a new momentum toward its solid implementation. The discussion will engage commissioners (contributors to the report), other high-level actors and experts from the European institutions, and patient representatives. Key topics of the report will be discussed, as well as how the European Union policy and funding initiatives can support both the recommendations and application of good practices throughout the EU.
The goal of saving the lives of almost 300,000 people per year across Europe is what is driving this initiative. Policy actions for marketing, pricing, and taxation of alcohol and unhealthy foods are of paramount importance with an ability to reduce premature morbidity and save these hundreds of thousands of lives per year across the region.
We warmly invite a broad range of stakeholders including primary care physicians, nurses, patients, peers, and members of relevant communities, along with medical specialists trained in obesity, diabetes, liver disease, oncology, cardiovascular disease, public health, addictions, infectious diseases, civil society organisations, representatives from patient organisations, policymakers, medical associations, and other actors involved in those topics in Europe and beyond.
Patrizia Burra (Italy) and Thomas Berg, EASL Secretary-General (Germany)
Richard Horton, Editor-in-Chief, The Lancet (United Kingdom)
Keynote statement on EU health policy
Ursula von der Leyen, President of the European Commission (Belgium)
Overview of the EASL-Lancet Liver Commission
Michael Manns, EASL–Lancet Commission Co-chair (Germany)
The burden of liver disease in Europe
Nick Sheron (United Kingdom)
Children and the power of digital marketing
Shira Zelber-Sagi (Israel)
Stigma as a barrier in pathways of liver care
Patrizia Carrieri (France)
Primary care hepatology
Rachel Pryke (United Kingdom)
A paradigm shift in hepatology
Pere Ginès (Spain)
Panel discussion: How to move from recommendations to action?
Q&A from audience
Future opportunities of a Lancet Commission
Sabine Kleinert, The Lancet (United Kingdom)
Tom Hemming Karlsen, EASL–Lancet Commission Co-chair (Norway)